NCT01801722 Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT01798420 Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation Status COMPLETED Phase N/A
NCT01797367 Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START) Status COMPLETED Phase N/A
NCT01793649 A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects Status TERMINATED Phase PHASE1
NCT01792271 Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis Status COMPLETED Phase NA
NCT01786928 The Role of Resistance Exercise in Chronic Obstructive Pulmonary Disease Exacerbation Status COMPLETED Phase NA
NCT01782768 Comparative Effects of Different Noninvasive Ventilation Mode on Neural Respiratory Drive in Recovering AECOPD Patients Status COMPLETED Phase NA
NCT01772342 Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung Disease Status COMPLETED Phase NA
NCT01768754 Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT01762917 Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing Status COMPLETED Phase N/A
NCT01761006 Evaluation of FeNO During and Following Acute COPD Exacerbation Status TERMINATED Phase N/A
NCT01759199 The Six-minute Stepper Test as an Outcome Measure of Exercise Tolerance During Pulmonary Rehabilitation in With Chronic Obstructive Pulmonary Disease (COPD) Patients(STEPPER)? Status COMPLETED Phase NA
NCT01757015 Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS Status WITHDRAWN Phase PHASE3
NCT01750489 Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic Activation Status COMPLETED Phase NA
NCT01745848 Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD Status COMPLETED Phase PHASE4
NCT01728220 Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD Status COMPLETED Phase PHASE2